Rhinoscleroma — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for rhinoscleroma. 20 active patents protecting 3 drugs from 3+ originators. First major cliff: 2030. Daily refresh.

3
Approved drugs
20
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered

Originators in Rhinoscleroma

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents AbbVie 4 patents Novartis 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating rhinoscleroma. Each bar = one year. Y-axis scaled to peak year (7 patents).

2
26
1
27
1
28
7
30
2
31
6
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Teflaro
CEFTAROLINE FOSAMIL
 AbbVie 4 61 — 2030-09-21
Tobi
tobramycin
 Novartis 2 72 — 2028-09-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
8869794 Tobi method of use 75 2028-09-12
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8247400 Teflaro method of use 73 2031-02-10
8247400 Teflaro method of use 73 2031-02-10
10207066 Tobi method of use 68 2030-11-04
8357394 Amoxil formulation 65 2026-12-08
9603806 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10238606 Amoxil formulation 42 2034-02-12
9629861 Teflaro formulation 48 2030-09-21
9629861 Teflaro formulation 48 2030-09-21
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11
9603806 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9498445 Amoxil method of use 62 2034-02-12

Related